Delving Further into the Funding Gap Between White and Black Researchers
As is now well known, black scientists are less successful than their white counterparts in obtaining support from NIH R01 awards as designated Principal Investigators (PIs) (see here and here). Though recent NIH efforts are showing promise to enhance diversity in the biomedical workforce (see this post), much work is still needed to address the funding gap.
In a paper recently published in Science Advances, we delved into the underlying factors associated with this funding gap. We identified three decision points where disparate outcomes arose between white and black researchers: 1) the decision to bring applications t...
Source: NIH Extramural Nexus - October 10, 2019 Category: Research Authors: Mike Lauer Tags: blog Open Mike application Diversity Funding data topic selection Source Type: funding
Pragmatic clinical trial on efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia (U01 Clinical Trial Required)
Funding Opportunity PA-19-230 from the NIH Guide for Grants and Contracts. This FOA invites applications for a pragmatic clinical trial to establish efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 28, 2019 Category: Research Source Type: funding
Evalution of Iron Species in Healthy Subjects treated with Generic and Reference Sodium Ferric Gluconate
This study is part of post-market surveillance on approved generic products, which can help address potential concerns regarding the quality of generic iron complex products and support the Agencys review standards.
Detailed Descriptions:
A prospective, randomized, 2-way crossover study to compare plasma TI, TBI, NTBI levels in healthy subjects treated with generic and reference sodium ferric gluconate injections is preferred. Utilize in vitro and in vivo biomarkers such as malondialdehyde, heme-oxygenase-1 (HO-1) RNA or others to evaluate the oxidative stress and toxicity caused by generic and RLD products.
1. Colle...
Source: Grants.gov - April 18, 2014 Category: Research Tags: Health Science and Technology and other Research and Development Source Type: funding
